|
| Perspective From Industry Leaders |
|
|
| Biden’s Pharma Plans Keep Industry Fighting On All Fronts | Biden Signs Sweeping Executive Order To Advance Women’s Health |
|
President’s State of the Union address doubled down on his desire to expand on the IRA... |
President Joe Biden signed an executive order the White House said represents the... |
| Licensing & Collaboration Agreements |
|
|
| AstraZeneca Pays $2bn To Keep Up With The Joneses | Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier |
|
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals... |
Plus deals involving BiomX/Adapative Phage, One/NEX-I, Shionogi/FunPep... |
| Next Gen R&D |
|
|
| Janux Soars On Early Efficacy, Safety For ‘Masked’ T-Cell Engagers | FDA Delay Will Not Push Rocket Pharma Off Its Trajectory |
|
Janux reported early clinical trial data for its lead asset JANX007 that may show differentiated... |
The gene therapy company could have two products approved by the end of 2024... |
| Clinical Trials |
|
|
| Crinetics May Have Drug Profile To Take Leading Position In Acromegaly | AI Clinical Summarization Tools Sit In 'Regulatory Grey Area', Experts Warn |
|
Reporting a second positive Phase III trial for oral paltusotine, Crinetics plans.... |
The EU lacks concrete guidance on whether clinical summarization large language... |
|
|
|
Citeline Contact Poornachandra Tejasvi .K, 
|
IPA Contact Name: Hari Pranav K |